Back to Search
MARI BETH STEIN, AGNP
AGNP
Nurse Practitioner
NPI: 1255870309IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nurse PractitionerPrimary
Nurse Practitioner
Code: 363L00000X
55255A(ID)
CMS Specialties
PrimaryNURSE PRACTITIONER
Education
OTHER
Class of 2016
Clinical Trials (6)
6
Linked Trials
1
Recruiting
3
With Results
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
NCT03781752RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
NCT01816074COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
NCT02675400COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
NCT02255565COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)
NCT00663442COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (11)
Increased Plasma Concentrations of 6-oxo-Methylphenidate inCarriers Following a Single Oral Dose of Methylphenidate.
PMID 41567292·Med Chem Res·2025
8-other
Sequencing Stimulant Medication and Behavioral Parent Training in Multiplex ADHD Families: A Pilot SMART.
PMID 40009046·J Clin Psychiatry·2025
2-rct
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
PMID 35201607·Cochrane Database Syst Rev·2022
1-meta
Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children.
PMID 32926603·J Clin Psychiatry·2020
4-observational
Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
PMID 28647012·J Am Acad Child Adolesc Psychiatry·2017
4-observational
Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
PMID 24942409·J Child Psychol Psychiatry·2015
4-observational
Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.
PMID 17201617·J Child Adolesc Psychopharmacol·2006
8-other
ADHD symptom subtypes in children with pervasive developmental disorder.
PMID 16477513·J Autism Dev Disord·2006
8-other
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
PMID 16275814·Arch Gen Psychiatry·2005
4-observational
Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
PMID 15827573·Neuropsychopharmacology·2005
3-trial
A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
PMID 14595084·Pediatrics·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 E IDAHO ST
BOISE, ID 83712 - Phone
- (208) 381-2790
Quick Facts
- NPI
- 1255870309
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 10
- Clinical Trials
- 6
- Publications
- 11
Are you this provider?
Claim Your Profile